SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-013888
Filing Date
2024-04-01
Accepted
2024-04-01 08:15:15
Documents
18
Period of Report
2024-04-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20240401.htm   iXBRL 8-K 31282
2 EX-99.1 aqstpr4124.htm EX-99.1 1734
6 aqstpr4124001.jpg GRAPHIC 119050
7 aqstpr4124002.jpg GRAPHIC 141522
8 aqstpr4124003.jpg GRAPHIC 143786
9 aqstpr4124004.jpg GRAPHIC 95963
  Complete submission text file 0001628280-24-013888.txt   846852

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20240401.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20240401_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20240401_pre.xml EX-101.PRE 12504
21 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20240401_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 24805657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)